Although previous studies have indicated a tumor-suppressive role for VPS25 [12,53], our current research reveals that VPS25 is significantly upregulated in HNSCC cells and correlates with poor clinical outcomes. This evidence concerns the gene VPS25 and head and neck squamous cell carcinoma.